Release Date: 09/04/19 13:21 Summary: Renounceable Rights Issue Price Sensitive: Yes Download Document 316.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%